首页> 外文期刊>Neurotoxicology and teratology >The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism.
【24h】

The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism.

机译:在存在和不存在帕金森综合症的情况下,亚慢性锰暴露对神经行为的影响。

获取原文
获取原文并翻译 | 示例

摘要

Recent studies have implicated chronic elevated exposures to environmental agents, such as metals (e.g., manganese, Mn) and pesticides, as contributors to neurological disease. In particular, there is a concern that sensitive subpopulations such as the aged may be at increased risk for the onset of neurologic disorders because elevated exposures to Mn is associated with increased incidence of parkinsonism. Here, we utilized a rat model of pre-parkinsonism to investigate the effects of Mn exposure on neurotoxicity and the exacerbation of parkinsonism. A pre-parkinsonism state was induced using a unilateral intrastriatal injection of 6-hydroxydopamine (6-OHDA), followed 4 weeks later by Mn exposure (4.8 mg Mn/kgx3 intraperitoneal injections/week) for 5 weeks. Female Sprague-Dawley rats (n=44) were divided among the following treatments: (A) control, saline/vehicle; (B) Mn only; (C) 6-OHDA only; and (D) 6-OHDA+Mn. Brain Mn levels were measured by ICP-MS. Neurobehavioral function was assessed following Mn exposure using a functional observational battery (FOB) consisting of 10 neurobehavioral tests. Unilateral 6-OHDA lesions produced significant ipsilateral vs. contralateral striatal dopamine depletions (60-70%), but no measurable impairment of neurobehavioral function, thereby substantiating this pre-parkinsonism (i.e., subthreshold) model. In contrast, Mn exposure resulted in significant impairment of neurobehavioral function for eight of the 10 FOB tests. No effects of Mn exposure on striatal dopamine depletion were detected, despite the 3.4-fold increase in brain Mn levels over controls. Notably, Mn exposure in the presence of a pre-parkinsonism state significantly exacerbated the neurobehavioral impairment in the reactivity to handling (P<.049) and hopping contralateral rear limb (P<.033) FOB tests. While the persistence and Mn dose-response relationship of these neurobehavioral effects were not evaluated here, these results nonetheless suggest that chronic Mn exposure may increase the risk of neurobehavioral impairment in subpopulations that are in a pre-parkinsonism state.
机译:最近的研究表明慢性增加了对环境因子的暴露,例如金属(例如,锰,锰)和杀虫剂,它们是导致神经系统疾病的原因。特别地,存在这样的担忧,即诸如老年人之类的敏感亚人群可能会出现神经系统疾病的风险增加,因为对Mn的暴露增加与帕金森综合征的发生率增加有关。在这里,我们利用帕金森病前期的大鼠模型来研究锰暴露对神经毒性和帕金森病加剧的影响。使用单侧纹状体内注射6-羟基多巴胺(6-OHDA)诱发帕金森病前状态,随后4周后进行Mn暴露(4.8 mg Mn / kgx3腹膜内注射/周),持续5周。将Sprague-Dawley雌性大鼠(n = 44)分为以下几种治疗方法:(A)对照,盐水/媒介; (B)仅锰; (C)仅6-OHDA; (D)6-OHDA + Mn。脑锰水平通过ICP-MS测量。锰暴露后,使用功能观察电池(FOB)评估神经行为功能,该功能电池由10个神经行为测试组成。单侧6-OHDA损伤产生了同侧和对侧纹状体多巴胺的大量消耗(60-70%),但没有可测量的神经行为功能受损,从而证实了这种帕金森氏病前(即阈下阈值)模型。相反,在10个FOB测试中,有8个暴露于锰会导致神经行为功能明显受损。尽管大脑中的锰水平比对照组增加了3.4倍,但并未发现Mn暴露对纹状体多巴胺消耗的影响。值得注意的是,在前帕金森氏病状态下暴露于锰会显着加剧神经行为损害,对操作性(P <.049)和对侧后肢跳跃(P <.033)FOB测试。尽管此处未评估这些神经行为的持久性和Mn剂量-反应关系,但这些结果仍然表明,长期暴露于Mn可能会增加处于帕金森病前状态的亚群神经行为受损的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号